Intercure Ltd. (INCR)
Market Closed
17 Jul, 15:25
TASE TASE Primary 
NASDAQ (NMS) 284. 90
ILA -0.4
-0.1402%
- Market Cap
- P/E Ratio
- Div Yield
51 Volume
- Eps
285.3 ILA
Previous Close Want to track INCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
INCR closed yesterday lower at 284.9 ILA, a decrease of -0.1402% from Thursday's close, completing a monthly decrease of -13.6667% or -45.1 ILA. Over the past 12 months, INCR stock lost -6.5902%.
INCR is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Intercure Ltd. has completed 3 stock splits, with the recent split occurring on Apr 08, 2021.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TASE (ILA).
INCR Chart
Intercure Ltd. (INCR) FAQ
What is the stock price today?
The current price is 284.90 ILA.
On which exchange is it traded?
Intercure Ltd. is listed on TASE.
What is its stock symbol?
The ticker symbol is INCR.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Intercure Ltd. ever had a stock split?
Intercure Ltd. had 3 splits and the recent split was on Apr 08, 2021.
Intercure Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Alexander Rabinovich CEO | TASE Exchange | IL0011063760 ISIN |
| IL Country | 320 Employees | - Last Dividend | 15 Jul 2012 Last Split | - IPO Date |
Overview
InterCure Ltd. is a prominent player in the medical cannabis industry, extending its footprint beyond its home country Israel to serve international markets. Founded in 1994 and based in Herzliya, Israel, the company has carved a niche in researching, cultivating, producing, and distributing pharmaceutical-grade cannabis and cannabis-based products tailored for medical applications. Besides its core operations in the cannabis sector, InterCure Ltd. also places strategic investments in the biomed sector, reflecting its broader vision in healthcare and medical innovations.
Products and Services
- Dried Cannabis Inflorescences: These are high-quality cannabis flowers cultivated under stringent controls to ensure pharmaceutical-grade quality. Used primarily for their therapeutic properties, they serve patients who rely on medical cannabis for relief from various conditions.
- Cannabis Extract Mixed with Oil: This product combines potent cannabis extracts with carrier oils to enhance bioavailability and ease of use. It's designed for patients seeking precise dosage and a more convenient consumption method than traditional flower products.
Contact Information
Address: 85 Medinat ha-Yehudim Street
Phone: 972 7 7460 5012
Website: https://www.intercure.co
